Senators Allegedly Dump Stock After To Private COVID-19 Briefings: Will There Be Consequences?

Several members of the U.S. Senate have allegedly been caught selling their stock prior to COVID-19 taking hold of the country.  Senators Richard Burr (R-N.C.), Kelly Loefler (R-G.A.), and Dianne Feinstein (D.-C.A.), among others, were purportedly privy to government meetings that discussed COVID-19’s trajectory across the globe as well as its potential health and economic impact.  While the public was still largely in the dark to the mortal danger of COVID-19—and before the stock market crashed—these senators sold millions of dollars in stock, averting the significant monetary losses that many other Americans have suffered.  People are now calling for, inter alia, the resignations of these senators as a result of their trading on material nonpublic COVID-19 information.  

By way of background, Section 10(b) of the Securities Exchange Act of 1934 makes it unlawful to purchase or sell a security “on the basis of material nonpublic information about that security or issuer, in breach of a duty of trust or confidence that is owed directly, indirectly, or derivatively, to the issuer of that security or the shareholders of that issuer, or to any other person who is the source of the material nonpublic information.”  17 C.F.R. § 240.10b5-1(a).  

In 2012, Congress passed the “Stop Trading on Congressional Knowledge Act of 2012” (the “STOCK Act”), which, inter alia, states that “[m]embers of Congress . . . are not exempt from the insider trading prohibitions arising under the securities laws, including section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder.”  See STOCK Act, Pub. L. No. 112–105, 126 Stat. 291 (2012).  The STOCK Act has codified Congress’ duty to the public by providing that “each Member of Congress . . .  owes a duty arising from a relationship of trust and confidence to the Congress, the United States Government, and the citizens of the United States with respect to material, nonpublic information derived from such person’s position as a Member of Congress . . .  or gained from the performance of such person’s official responsibilities.”  15 U.S.C. § 78u-1(g).  

If these senators violated their duty of trust to the American public by trading on non-public information regarding COVID-19, then they may have violated the securities laws for insider trading.  However, will they face actual consequences?  That remains to be seen.  

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour, personal injury and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Delaware, Georgia and Pennsylvania.

Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.

To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.

About Sherief Morsy

Sherief Morsy's practice is focused on securities litigation. Sherief is a Senior Associate in the firm's New York office.

Tags: faruqi & faruqi, investigation, news, litigation, settlement notice, case, faruqi law, faruqi blog, faruqilaw, Sherief Morsy, securities litigation Sherief Morsy Sherief Morsy
Senior Associate at Faruqi & Faruqi, LLP

New York office
Tel: (212) 983-9330
Fax: (212) 983-9331

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885


3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612


3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania